Homeopathic Drug Recall: Vaccinotoxinum Products Due to Manufacturing Violations
Washington Homeopathic Products is recalling Vaccinotoxinum homeopathic remedies (lot numbers 2512K and 20280) distributed nationwide due to cGMP manufacturing deviations. The voluntary recall was initiated by the firm in May 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for manufacturing process (cGMP) deviations. No illnesses or injuries are reported in the source. Per the severity rubric, Class II recalls with no hospitalization reports and no reported safety events score as Moderate (2).
Plain-English summary
Washington Homeopathic Products, Inc. has recalled Vaccinotoxinum homeopathic remedies in multiple potencies (32X, 11C, and 30C). The recalled products come in 2 glass amber bottles and were distributed nationwide, identified by lot numbers 2512K and 20280.
The recall was initiated on May 13, 2022, due to cGMP (Current Good Manufacturing Practice) deviations—violations of manufacturing quality standards. Washington Homeopathic Products voluntarily initiated the recall and notified customers by letter. The FDA classified this as a Class II recall.
Consumers who have these products should contact their healthcare provider or pharmacist to discuss whether the product should be returned or discarded. The recall was terminated on May 25, 2023.
The recalled product
- Product
- Vaccinotoxinum, Potency: 32X, 11C, 30C, Liquid Pellets, Rx only, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic Remedy
- Hazard
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 2512K
- 20280
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01